InvestorsHub Logo

DewDiligence

04/17/24 3:37 PM

#251481 RE: Biowatch #250950

LLY’s Zepbound—>statsig clinical benefit_in sleep-apnea phase-3 trials:

https://www.fiercepharma.com/pharma/eli-lillys-tirzepatide-scores-again-time-2-sleep-apnea-trials